MR [Mindray Medical International] 6-K: Mindray Appoints Ms.Fannie Lin Fan Generalunsel SHENZHEN, China,

[Mindray Appoints Ms.Fannie Lin Fan Generalunsel SHENZHEN, China, May23, 2011 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Ms.Fannie Lin Fan Generalunsel of thempany. Ms.Fan will join Mindray in June2011, succeeding Mr.Tim Fitzpatrick, who will step down to pursue other]

SSW [Seaspan] 424B5: ABOUT THIS PROSPECTUS SUPPLEMENT This document is in

[ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the “prospectus,” we are referring to both parts]

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months Ended March 31, 2011 and 2010 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011]

By | 2016-02-05T03:39:38+00:00 May 23rd, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months Ended March 31, 2011 and 2010 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011]

By | 2016-02-05T03:40:32+00:00 May 23rd, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] 20-F: (Original Filing)

[2 TABLE OFNTENTS PART I Item 1. Identity of Directors, Senior Management andvisors [5] Item 2. Offer Statistics and Expected Timetable [5] Item 3. Key Information [5] Item 4. Information on thempany [14] Item 4A. Unresolved Staffmments [21] Item 5. Operating and Financial Review and Prospects [21]] [Significant Subsidiaries of O2MICRO INTERNATIONAL LIMITED 2 2 2 2 2 2 2 2 Internationalsetmpany, ayman Islandsmpany exh_81.htm 2 EX-8] [CERTIFICATION I, Sterling Du, certify that: 1. 2 I have reviewed this annual report on Form 20-F of O 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Perry Kuo, certify that: 1. O 2 Micro I have reviewed this annual report on Form 20-F of 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [O2Micro International Limited CERTIFICATION 2 Micro International Limited (thempany) on Form 20-F for the (1) (2) the informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Sterling Du Chief Executive Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 Wensent to theorporation by reference in Registration Statement Nos. 333-12670, 333-12672, 333-98425, 333-101452, 333-107975, 333-116596, 333-132251,333-153436 and 333-162489 on Form S-8 of our reportsted April 29, 2011 relating to thensolidated financial statements of O Deloitte & Touche Taipei, Taiwan]

By | 2016-02-06T03:46:42+00:00 May 23rd, 2011|Categories: Chinese Stocks, OIIM, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar